Australian Medical Association
AMA members are asked to participate in a survey for the Department of Health.
The Department of Health and Aged Care is seeking prescriber and other stakeholder feedback about the use of the List of Medicines for Brand Consideration (LMBC) as a support tool to prescribing by brand name in addition to active ingredient, under the Active Ingredient Prescribing (AIP) Program.
The survey is open until 13 November 2023 by clicking the following link: https://consultations.health.gov.au/technology-assessment-access-division/consultation-on-the-active-ingredient-prescribing
/AMA/AusMed News. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
